A US study of web sites selling controlled prescription medications has found that a number of sites which are illicit have been in operation for more than a year and are being operated from within the USA.
This discovery suggests that law enforcement operations against the sites are possible, says the report, adding that "a concerted, programmatic effort" to take them down could have a significant impact on illicit product availability.
The investigation was conducted by New Jersey-based firm IntegriChain on behalf of the US House Energy and Commerce Committee's subcommittee on oversight and investigations, which conducted hearings in December 2005 on ways in which efforts to combat Internet sales of controlled substances might be strengthened.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze